What is MRNA's dilution risk score?

MRNA has a latest available DilutionScore record of 50/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for MRNA, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for MRNA?

DilutionWatch tracks 25 SEC filing types for MRNA including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect MRNA shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For MRNA, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for MRNA tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for MRNA. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

MRNA Dilution Risk Score: 50/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

20

💰 Cash Runway

85

📊 Float Risk

7

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 17%

💰 Capital Raise model 35%

• Low cash runway: 5 months remaining

🔔 Track MRNA — Get forecast alerts →

Market Data

Market Cap$18.72B

Shares Outstanding399.24M

Float370.10M

Cash$1.72B

Debt$591.00M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 13.6% shares (2026Q1 vs prior)

741 institutional holders · 452.91M shares

#1 VANGUARD CAPITAL MANAGEMENT LLC 45.74M shares

#2 FMR LLC 45.67M shares

#3 BlackRock, Inc. 29.64M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest49.77M

Days to Cover10.2

% of Float13.4%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

Form 4 INSIDER TRANSACTION 2026-08-06

Form 4 INSIDER TRANSACTION 2026-08-05

Full SEC filing analysis available with free account →

Recent News

Jim Cramer Says Hold on to Moderna (MRNA) After Phase 3 Cancer Trial Insider Monkey · Aug 28

Q2 Earnings Highlights: Moderna (NASDAQ:MRNA) Vs The Rest Of The Therapeutics St StockStory · Aug 28

Moderna (MRNA) & Merck (MRK): What’s Happening With These Two Stocks? Insider Monkey · Aug 28

Factual MRNA Dilution Snapshot

Moderna, Inc. (MRNA) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for MRNA: Form 4 on 2026-08-06; Form 4 on 2026-08-06; Form 4 on 2026-08-06.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.